215 related articles for article (PubMed ID: 23272181)
21. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress.
Winokur ST; Barrett K; Martin JH; Forrester JR; Simon M; Tawil R; Chung SA; Masny PS; Figlewicz DA
Neuromuscul Disord; 2003 May; 13(4):322-33. PubMed ID: 12868502
[TBL] [Abstract][Full Text] [Related]
22. Facioscapulohumeral Muscular Dystrophy is Associated With Altered Myoblast Proteome Dynamics.
Nishimura Y; Bittel AJ; Stead CA; Chen YW; Burniston JG
Mol Cell Proteomics; 2023 Aug; 22(8):100605. PubMed ID: 37353005
[TBL] [Abstract][Full Text] [Related]
23. Antisense Oligonucleotides Used to Target the DUX4 mRNA as Therapeutic Approaches in FaciosScapuloHumeral Muscular Dystrophy (FSHD).
Ansseau E; Vanderplanck C; Wauters A; Harper SQ; Coppée F; Belayew A
Genes (Basel); 2017 Mar; 8(3):. PubMed ID: 28273791
[TBL] [Abstract][Full Text] [Related]
24. Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.
Oliva J; Galasinski S; Richey A; Campbell AE; Meyers MJ; Modi N; Zhong JW; Tawil R; Tapscott SJ; Sverdrup FM
J Pharmacol Exp Ther; 2019 Aug; 370(2):219-230. PubMed ID: 31189728
[TBL] [Abstract][Full Text] [Related]
25. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
Richards M; Coppée F; Thomas N; Belayew A; Upadhyaya M
Hum Genet; 2012 Mar; 131(3):325-40. PubMed ID: 21984394
[TBL] [Abstract][Full Text] [Related]
26. Membrane Repair Deficit in Facioscapulohumeral Muscular Dystrophy.
Bittel AJ; Sreetama SC; Bittel DC; Horn A; Novak JS; Yokota T; Zhang A; Maruyama R; Rowel Q Lim K; Jaiswal JK; Chen YW
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759720
[TBL] [Abstract][Full Text] [Related]
27. β-Catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy.
Banerji CR; Knopp P; Moyle LA; Severini S; Orrell RW; Teschendorff AE; Zammit PS
J R Soc Interface; 2015 Jan; 12(102):20140797. PubMed ID: 25551153
[TBL] [Abstract][Full Text] [Related]
28. Facioscapulohumeral dystrophy myoblasts efficiently repair moderate levels of oxidative DNA damage.
Bou Saada Y; Dib C; Dmitriev P; Hamade A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
Histochem Cell Biol; 2016 Apr; 145(4):475-83. PubMed ID: 26860865
[TBL] [Abstract][Full Text] [Related]
29. Asymmetric bidirectional transcription from the FSHD-causing D4Z4 array modulates DUX4 production.
Block GJ; Petek LM; Narayanan D; Amell AM; Moore JM; Rabaia NA; Tyler A; van der Maarel SM; Tawil R; Filippova GN; Miller DG
PLoS One; 2012; 7(4):e35532. PubMed ID: 22536400
[TBL] [Abstract][Full Text] [Related]
30. Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways.
Rickard AM; Petek LM; Miller DG
Hum Mol Genet; 2015 Oct; 24(20):5901-14. PubMed ID: 26246499
[TBL] [Abstract][Full Text] [Related]
31. miR-411 is up-regulated in FSHD myoblasts and suppresses myogenic factors.
Harafuji N; Schneiderat P; Walter MC; Chen YW
Orphanet J Rare Dis; 2013 Apr; 8():55. PubMed ID: 23561550
[TBL] [Abstract][Full Text] [Related]
32. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
[TBL] [Abstract][Full Text] [Related]
33. Generation of isogenic D4Z4 contracted and noncontracted immortal muscle cell clones from a mosaic patient: a cellular model for FSHD.
Krom YD; Dumonceaux J; Mamchaoui K; den Hamer B; Mariot V; Negroni E; Geng LN; Martin N; Tawil R; Tapscott SJ; van Engelen BG; Mouly V; Butler-Browne GS; van der Maarel SM
Am J Pathol; 2012 Oct; 181(4):1387-401. PubMed ID: 22871573
[TBL] [Abstract][Full Text] [Related]
34. DUX4c is up-regulated in FSHD. It induces the MYF5 protein and human myoblast proliferation.
Ansseau E; Laoudj-Chenivesse D; Marcowycz A; Tassin A; Vanderplanck C; Sauvage S; Barro M; Mahieu I; Leroy A; Leclercq I; Mainfroid V; Figlewicz D; Mouly V; Butler-Browne G; Belayew A; Coppée F
PLoS One; 2009 Oct; 4(10):e7482. PubMed ID: 19829708
[TBL] [Abstract][Full Text] [Related]
35. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
[TBL] [Abstract][Full Text] [Related]
36. PAX7 target gene repression is a superior FSHD biomarker than DUX4 target gene activation, associating with pathological severity and identifying FSHD at the single-cell level.
Banerji CRS; Zammit PS
Hum Mol Genet; 2019 Jul; 28(13):2224-2236. PubMed ID: 31067297
[TBL] [Abstract][Full Text] [Related]
37. Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.
Jagannathan S; Shadle SC; Resnick R; Snider L; Tawil RN; van der Maarel SM; Bradley RK; Tapscott SJ
Hum Mol Genet; 2016 Oct; 25(20):4419-4431. PubMed ID: 28171552
[TBL] [Abstract][Full Text] [Related]
38. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.
Jones TI; Chen JC; Rahimov F; Homma S; Arashiro P; Beermann ML; King OD; Miller JB; Kunkel LM; Emerson CP; Wagner KR; Jones PL
Hum Mol Genet; 2012 Oct; 21(20):4419-30. PubMed ID: 22798623
[TBL] [Abstract][Full Text] [Related]
39. Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei.
Masny PS; Chan OY; de Greef JC; Bengtsson U; Ehrlich M; Tawil R; Lock LF; Hewitt JE; Stocksdale J; Martin JH; van der Maarel SM; Winokur ST
Eur J Hum Genet; 2010 Apr; 18(4):448-56. PubMed ID: 19888305
[TBL] [Abstract][Full Text] [Related]
40. Defective regulation of microRNA target genes in myoblasts from facioscapulohumeral dystrophy patients.
Dmitriev P; Stankevicins L; Ansseau E; Petrov A; Barat A; Dessen P; Robert T; Turki A; Lazar V; Labourer E; Belayew A; Carnac G; Laoudj-Chenivesse D; Lipinski M; Vassetzky YS
J Biol Chem; 2013 Dec; 288(49):34989-5002. PubMed ID: 24145033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
